ENTX Entera Bio Ltd.

Overview and Growth

In fiscal 2025, Entera Bio Ltd. recorded $42.00K of revenue, net loss of $11.44M, and an operating cash outflow of $7.37M. The $42.00K revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line contracted 76.8% from $181.00K in fiscal 2024; this top-line contraction left the company with a smaller revenue base. The company reported diluted EPS of $0.25, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $0.25 in fiscal 2024, the current result was 0.0% higher. A diluted share base of 46.19M links the aggregate earnings figure to diluted EPS and helps frame the per-share comparison. Compared with 37.65M diluted shares in fiscal 2024, the current 46.19M base was 22.7% higher. The company employed $15.99M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Asset turnover was 0.0x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Gross profit was $0.00, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The gross-profit relationship equaled 0.0% of revenue, quantifying the portion retained before operating expenses were recognized. The reported operating result was an operating loss of $11.53M, reflecting costs that exceeded gross profit. The company ended the period with a net loss of $11.44M, extending the operating result through all remaining items. EBITDA was negative $11.50M, showing a deficit before interest, taxes, depreciation, and amortization. The pretax result was a loss of $11.44M, establishing the deficit before tax effects. Income tax expense totaled $0.00, providing the reported tax component that separates pretax and after-tax earnings. Relative to period-end equity, the net loss represented 87.3%. Relative to total assets, the net loss represented 71.5%. Compared with a $9.54M net loss in fiscal 2024, the current loss increased to $11.44M.

Liquidity and Capital Structure

Total assets were $15.99M, supported by $2.89M of liabilities and $13.10M of shareholder equity. The near-term balance sheet paired $15.30M of current assets with $2.20M of current liabilities at the reporting date. Current assets covered current liabilities by 6.94x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $7.11M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 322.7% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Book equity represented 81.9% of total assets, quantifying the balance-sheet share supported by shareholder capital. Liabilities represented 18.1% of total assets, quantifying the liability-funded share of the company’s resource base. Cash and equivalents equaled 44.4% of total assets, showing the liquid cash component within the company’s broader resource base. The asset base changed 70.3% from $9.39M in fiscal 2024, leaving current total assets higher year over year. Book equity was 62.1% higher than fiscal 2024 equity of $8.08M, showing how shareholder capital changed year over year. Cash and equivalents were 17.9% lower than fiscal 2024 cash of $8.66M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $7.37M, showing that operations absorbed cash during the period. The company spent $107.00K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Negative free cash flow was $7.48M, leaving a cash deficit after capital spending and reducing financial flexibility. The cash deficit after capital spending represented 46.8% of the period-end asset base. Cash absorbed by operations increased from $6.82M in fiscal 2024 to $7.37M.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 26, 2026.